J. Hellings

发表

The overt aggression scale for rating aggression in outpatient youth with autistic disorder: preliminary findings.

J. Hellings, E. Nickel, Marilyn Weckbaugh, 2005, The Journal of neuropsychiatry and clinical neurosciences.

The MOVES: A Self-Rating Scale for Tourette's Syndrome

J. Hellings, G. Gaffney, K. Sieg, 1994 .

Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders.

Seemalata Jain, J. Hellings, S. Jadhav, 2015, Journal of child and adolescent psychopharmacology.

Intellectual Disability and Ill Health: Congenital causes

J. Hellings, M. Butler, J. Grant, 2010 .

Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.

Tristram H. Smith, J. Hellings, X. Pan, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review

R. Andridge, Seemalata Jain, J. Hellings, 2016, Journal of autism and developmental disorders.

A clinical report and further delineation of the 14q32 deletion syndrome

J. Hellings, M. Butler, Erin L. Youngs, 2011, Clinical dysmorphology.

Incorporation of Telepsychiatry for Patients with Developmental Disorders into Routine Clinical Practice—A Survey of Specialty Clinics Adapting to Telepsychiatry During the COVID-19 Pandemic

Kathleen A. Koth, J. Hellings, R. Muhle, 2022, Journal of Autism and Developmental Disorders.

Psychiatry training in autism spectrum disorder and intellectual disability: Ongoing gaps and emerging opportunities.

Kathleen A. Koth, J. Hellings, R. Muhle, 2022, Autism : the international journal of research and practice.

IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features.

J. Hellings, M. Butler, R. Henkhaus, 2012, European journal of medical genetics.

Psychopharmacology of mood disorders in persons with mental retardation and autism

J. Hellings, 1999 .

ANKRD11 gene deletion in a 17-year-old male.

J. Hellings, M. Butler, Erin L. Youngs, 2011, Clinical dysmorphology.

Psychopathology, GABA, and the Rubinstein-Taybi syndrome: a review and case study.

J. Hellings, S. Hossain, Judy K. Martin, 2002, American journal of medical genetics.

A Retrospective Study of Amitriptyline in Youth with Autism Spectrum Disorders

J. Hellings, H. Yeh, G. Cook-Wiens, 2012, Journal of Autism and Developmental Disorders.

A Crossover Study of Risperidone in Children, Adolescents and Adults with Mental Retardation

J. Hellings, S. Schroeder, J. Zarcone, 2006, Journal of autism and developmental disorders.

Maternal immune activation and abnormal brain development across CNS disorders

Irene Knuesel, M. Britschgi, J. Hellings, 2014, Nature Reviews Neurology.

Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism.

Tristram H. Smith, J. Hellings, X. Pan, 2017, Journal of child and adolescent psychopharmacology.

Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline

L Eugene Arnold, J. Hellings, L. E. Arnold, 2017, Expert opinion on pharmacotherapy.

Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.

R. Andridge, J. Hellings, M. Butler, 2015, Journal of child and adolescent psychopharmacology.

Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders.

J. Hellings, S. Schroeder, J. Zarcone, 2005, Journal of child and adolescent psychopharmacology.

A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders.

E. Cook, J. Hellings, E. Nickel, 2005, Journal of child and adolescent psychopharmacology.

A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders.

E. Cook, J. Hellings, E. Nickel, 2005, Journal of child and adolescent psychopharmacology.

Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions.

J. Hellings, S. Schroeder, J. Zarcone, 2002, Experimental and clinical psychopharmacology.

Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures.

S R Schroeder, J. Hellings, S. Schroeder, 2001, American journal of mental retardation : AJMR.

How to Make Effective Evaluation of Psychotropic Drug Effects in People with Developmental Disabilities and Self-Injurious Behavior

J. Hellings, S. Schroeder, A. Courtemanche, 2013 .

Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis.

J. Hellings, S. Schroeder, T. McKerchar, 2004, American journal of mental retardation : AJMR.

A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.

J. Brian, E. Anagnostou, J. Veenstra-VanderWeele, 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.

J. Brian, E. Anagnostou, J. Veenstra-VanderWeele, 2016, JAMA psychiatry.

Genetics and Mitochondrial Abnormalities in Autism Spectrum Disorders: A Review

J. Hellings, M. Butler, S. Dhillon, 2011, Current genomics.

Training of child and adolescent psychiatry fellows in autism and intellectual disability

E. Cook, J. Pruett, B. King, 2014, Autism : the international journal of research and practice.

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.

J. Hellings, S. Schroeder, J. Zarcone, 2001, Journal of child and adolescent psychopharmacology.

Sertraline response in adults with mental retardation and autistic disorder.

J. Hellings, W. Gabrielli, L. A. Kelley, 1996, The Journal of clinical psychiatry.

Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures.

J. Hellings, S. Schroeder, J. Zarcone, 2002, American journal of mental retardation : AJMR.

Treatment methods for destructive and aggressive behaviour in people with severe developmental and intellectual disabilities

J. Hellings, N. Bouras, G. Holt, 2001 .

12-year-old boy with a 4q35.2 microdeletion and involvement of MTNR1A, FAT1, and F11 genes

J. Hellings, M. Butler, R. Henkhaus, 2012, Clinical dysmorphology.

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

C. McDougle, D. Posey, H. Nagaraja, 2015, Journal of child and adolescent psychopharmacology.

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Tristram H. Smith, J. Hellings, X. Pan, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Self-injurious behavior and serotonin in Prader-Willi syndrome.

J. Hellings, J. Warnock, 1994, Psychopharmacology bulletin.

Developing Freely Accessible Educational Videos to Enhance Knowledge of Autism Spectrum Disorder and Intellectual Disability.

Kathleen A. Koth, J. Hellings, R. Muhle, 2021, Journal of the American Academy of Child and Adolescent Psychiatry.

Long-Term Aripiprazole in Youth With Developmental Disabilities Including Autism

J. Hellings, S. Schroeder, M. Butler, 2011, Journal of mental health research in intellectual disabilities.

Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression in Children and Adolescents

J. Hellings, Susan Sharp, 2006, Clinical drug investigation.

Gender Diverse Autistic Young Adults: A Mental Health Perspective

J. Hellings, A. Genovese, Saras Chen Singh, 2022, Archives of Sexual Behavior.

Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry

J. Hellings, M. Butler, Erin L. Youngs, 2012, Autism research and treatment.

An 18‐year follow‐up report on an infant with a duplication of 9q34

N. Spinner, J. Hellings, M. Butler, 2010, American journal of medical genetics. Part A.

Velocardiofacial Syndrome-Associated Psychiatric Illness and Response to Aripiprazole: A Case Study.

J. Hellings, M. Butler, Richard R Brewington, 2008, The American journal of psychiatry residents' journal.

SPECT Brain Imaging Abnormalities in Attention Deficit Hyperactivity Disorder

D. F. Preston, J. Hellings, G. Gaffney, 1995, Clinical nuclear medicine.

A Retrospective Study of Amitriptyline in Youth with Autism Spectrum Disorders

J. Hellings, H. Yeh, G. Cook-Wiens, 2013, Journal of autism and developmental disorders.

Use of Functional Analysis Methodology in the Evaluation of Medication Effects

J. Hellings, S. Schroeder, J. Zarcone, 2003, Journal of autism and developmental disorders.

World Journal of Psychiatry

J. Hellings, 2022 .